The US Food and Drug Administration (FDA) has issued a warning against counterfeit Ozempic (semaglutide) weight-loss shots found in the supply chain. The FDA and manufacturer Novo Nordisk are investigating and testing seized products. Consumers and healthcare providers are warned not to use products labelled with specific serial numbers. The pens, needles, and information have been found to be counterfeit, posing potential health risks. The FDA recommends buying only through authorized distributors and state-licensed facilities.
Pakistani Threat Actors Targeting Indian Govt. With Email Mimic as ‘NIC eEmail Services’
A sophisticated phishing campaign orchestrated by Pakistan-linked threat actors has been discovered targeting Indian government entities by impersonating the National Informatics Centre’s email services. The
